NYSE:ABBV (AbbVie)
About ABBV
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. The company's primary product is Humira, administered via injection.
AbbVie (NYSE: ABBV) Latest News
Investing Articles
3 top US dividend stocks for value investors to consider in 2024
Investing Articles
2 great dividend shares I’m buying now
Investing Articles
2 great dividend shares I’m buying now
Investing Articles
3 pharma stocks to watch in April
Investing Articles
Should I Invest In Direct Line Insurance Group PLC, Mountview Estates plc And Shire PLC Now?
Investing Articles
Is Shire PLC A Buy After AbbVie Inc Withdraws Takeover Offer?
Investing Videos
A Closer Look At Shire PLC
Investing Articles
Why AbbVie Inc Is Buying Shire PLC
Company Comment
Shire PLC Accepts £32bn Takeover By AbbVie Inc
Investing Articles
One Reason Why AstraZeneca plc Is A Risky Bet
Company Comment
Shire PLC Willing To Recommend £32bn Bid From AbbVie Inc
Investing Articles
AbbVie Inc’s Raised Bid Confirms My Shire PLC Sell Rating
1❯